Cargando…

T cells in pancreatic cancer stroma

Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with a dismal 5-year survival rate. PDAC has a complex tumour microenvironment; characterised by a robust desmoplastic stroma, extensive infiltration of immunesuppressive cells such as immature myeloid cells, tumour-associated m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goulart, Michelle R, Stasinos, Konstantinos, Fincham, Rachel Elizabeth Ann, Delvecchio, Francesca R, Kocher, Hemant M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678814/ https://www.ncbi.nlm.nih.gov/pubmed/35046623 http://dx.doi.org/10.3748/wjg.v27.i46.7956

Ejemplares similares

B cells in pancreatic cancer stroma
por: Delvecchio, Francesca Romana, et al.
Publicado: (2022)

Natural killer cells in pancreatic cancer stroma
por: Fincham, Rachel Elizabeth Ann, et al.
Publicado: (2021)

Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma
por: Di Maggio, Francesco, et al.
Publicado: (2016)

Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects
por: Polani, Faran, et al.
Publicado: (2021)

The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration
por: Watt, Jennifer, et al.
Publicado: (2013)

Tumour–stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness
por: Le, N H, et al.
Publicado: (2008)

Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records
por: Dayem Ullah, Abu Z. M., et al.
Publicado: (2021)

Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice
por: Delvecchio, Francesca R., et al.
Publicado: (2021)

Arachidonate 15-lipoxygenase-mediated production of Resolvin D5(n-3 DPA) abrogates pancreatic stellate cell-induced cancer cell invasion
por: Aguirre, Gabriel A., et al.
Publicado: (2023)

BRCA mutated pancreatic cancer: A change is coming
por: Rosen, Michael N, et al.
Publicado: (2021)

The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022)

Current role of palliative interventions in advanced pancreatic cancer
por: Ciambella, Chelsey C, et al.
Publicado: (2018)

Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma
por: Di Carlo, Claudia, et al.
Publicado: (2018)

Pancreatic cancer: New hopes after first line treatment
por: Aroldi, Francesca, et al.
Publicado: (2016)

Exploiting inflammation for therapeutic gain in pancreatic cancer
por: Steele, C W, et al.
Publicado: (2013)

Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021)

Pancreatic cancer and depression
por: Michoglou, Kalliopi, et al.
Publicado: (2023)

Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations
por: Poddighe, Dimitri
Publicado: (2021)

Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer
por: Petrov, Maxim S
Publicado: (2021)

Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy
por: Moniaux, N, et al.
Publicado: (2004)

Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis
por: Kunovsky, Lumir, et al.
Publicado: (2021)

Impact of surgery for chronic pancreatitis on the risk of pancreatic cancer: Untying the Gordian knot
por: Kalayarasan, Raja, et al.
Publicado: (2021)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Neoadjuvant therapy for resectable pancreatic cancer
por: Rahman, Sheikh Hasibur, et al.
Publicado: (2017)

Pancreatic acinar cell carcinoma: A comprehensive review
por: Calimano-Ramirez, Luis Fernando, et al.
Publicado: (2022)

Prognostic significance of red blood cell distribution width in gastrointestinal disorders
por: Goyal, Hemant, et al.
Publicado: (2017)

Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer
por: Ko, Sung Woo, et al.
Publicado: (2023)

Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021)

Sarcopenia in pancreatic cancer: Effect on patient outcomes
por: Choi, Moon Hyung, et al.
Publicado: (2022)

Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
por: Nishimoto, Arata
Publicado: (2022)

Role of human nucleoside transporters in pancreatic cancer and chemoresistance
por: Carter, Carly Jade, et al.
Publicado: (2021)

Sarcopenia in pancreatic cancer – effects on surgical outcomes and chemotherapy
por: Chan, Miu Yee, et al.
Publicado: (2019)

Endoscopic ultrasound guided interventions in the management of pancreatic cancer
por: Kerdsirichairat, Tossapol, et al.
Publicado: (2022)

Impact of microbiota-immunity axis in pancreatic cancer management
por: Bartolini, Ilenia, et al.
Publicado: (2022)

Incretin based therapy and pancreatic cancer: Realising the reality
por: Suryadevara, Varun, et al.
Publicado: (2022)

Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care
por: Hamad, Ahmad, et al.
Publicado: (2021)

Revisiting stroma in pancreatic cancer
por: Khan, Sheema, et al.
Publicado: (2015)

Pancreatic cancer, stroma, and exosomes
por: Closa, Daniel
Publicado: (2022)

Nanotechnology and pancreatic cancer management: State of the art and further perspectives
por: Caputo, Damiano, et al.
Publicado: (2021)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hgi0pfaf34fpkp1j70qj7v72q5